Cavalier Investments’s iShares Biotechnology ETF IBB Stock Holding History

Cavalier Investments’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-6,807	Closed	-$930K	–	72
2020 Q2	$930K	Hold	6,807	–	–	0.54%	58
2020 Q1	$733K	Sell	6,807 -37,860	-85%	-$4.36M	0.43%	55
2019 Q4	$5.38M	Buy	+44,667	New	+$4.98M	2.33%	10
2019 Q3	–	Sell	-31,263	Closed	-$3.41M	–	127
2019 Q2	$3.41M	Buy	31,263 +10,305	+49%	+$1.1M	1.43%	20
2019 Q1	$2.34M	Buy	+20,958	New	+$2.3M	0.96%	26

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Churchill Management Los Angeles, California $9.21B AUM 19.91% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Cavalier Investments's IBB Position: Q3 2020 in Review

Cavalier Investments sold out of iShares Biotechnology ETF (IBB) in Q3 2020, closing a stake of 6,807 shares — an estimated $930K sold.

Cavalier Investments first reported a position in IBB in Q1 2019 and held it in 5 quarters. The position peaked at $5.38M in Q4 2019. 784 funds tracked by Wall St. Rank hold IBB as of Q3 2020.

Cavalier Investments reported no remaining iShares Biotechnology ETF position as of Q3 2020 after selling out during the quarter.
Cavalier Investments sold 6,807 iShares Biotechnology ETF shares in Q3 2020, an estimated $930K.
Cavalier Investments first reported a position in iShares Biotechnology ETF in Q1 2019 and held it in 5 quarters.
Cavalier Investments's iShares Biotechnology ETF position peaked at $5.38M in Q4 2019.
784 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2020.

Based on Cavalier Investments's 13F filing for Q3 2020, filed 12 Nov 2020.